INTRODUCTION
Ever since the deciphering of the genetic code, increasing knowledge in the genetic etiology of numerous ailments together with remarkable advances in molecular biology have opened new therapeutic possibilities for otherwise incurable diseases. One of the main roadblocks holding back more significant and widespread clinical success for gene therapy is the development of efficient and safe carriers, able to deliver a genetic cargo to target cells and tissues. Owing to millions of years of evolution in optimizing transport of their genomes to mammalian cells, viruses continue to be the most efficient carriers to deliver a genetic payload. This is reflected by the fact that almost 70% of all gene therapy clinical trials performed to date have used viral vectors. 1 However, significant efforts to avoid random genomic integration and diminish immunogenicity have yet failed to completely address the safety concerns raised by the use of these powerful biological carriers. Limited capacity to accommodate very long nucleic acids, together with their elevated production costs and challenging batch-to-batch variation on upscaling, further challenge the widespread adoption of these vector systems. 2 In contrast, the development of non-viral vectors that are in principle safer and more adaptable to upscale has so far been mainly hampered by compromised transfer and expression efficiency. Despite the many different materials explored as components of non-viral vectors, including cationic lipids, polymers, dendrimers and polysaccharides, 3 none has managed to match the biological efficacy obtained with viral vectors. In addition, the excess of positive charges required to complex nucleic acid cargos and facilitate endosomal escape intracellularly is often the cause of unwanted cytotoxicity and inflammation. 4 The recent discovery of two-dimensional, mono-atomic carbonbased graphene materials [5] [6] [7] and their chemical derivatives, 8 has added a new range of options for the design and fabrication of non-viral gene delivery vectors. In this article, we first analyze the remarkable physicochemical, optical and photothermal properties that have raised the interest on graphene-based materials (GBMs) as gene delivery vectors to then provide a comprehensive review of the studies published to date on this topic (summarized in Table 1 ). Special attention will be paid to the surface functionalization and modification strategies performed to GBMs to optimize them as gene delivery vectors, as well as to the biological activity and efficacy achieved.
WHAT CAN GBMS OFFER AS GENE DELIVERY PLATFORMS?
Graphene is a two-dimensional material which consists of a single atomic layer of sp2 hybridized carbon atoms organized in a honeycomb lattice. Its unique physical, thermal and electrical abilities have generated great interest in several research areas such as physics and electronics since its discovery in 2004. 6 Its oxidized form, graphene oxide (GO), retains these remarkable propertie and offers facile aqueous dispersibility and biocompatibility that make it a better candidate for biomedical applications. hydroxyls offers further derivation possibilities such as amidation through epoxy ring opening and esterification. 11 Most of such reactions take place in the presence of coupling agents such as 1-Ethyl-3-(3-dimethylaminopropide)carbodiimide (EDC) or N-hydroxysuccinimide (NHS). In addition, GBMs can not only act as electron donating ligands to establish π-π stacking but also as electron acceptors in the case of physisorption. This mostly occurs via electrostatic interactions, Van der Waals forces and hydrogen bonds. 12 Such variety of chemical routes therefore offers numerous possibilities for the functionalization of GBMs in order to (a) tailor their pharmacokinetic properties and enhance their biocompatibility, 13 (b) engraft cationic molecules to increase nucleic acid (NA) loading efficiency, (c) incorporate water insoluble drugs or molecules that are subject to drug resistance mechanisms 14 and (d) incorporate imaging agents. 15 Ability to condense genetic material The capability of GBMs to bind NA has been widely reported in the case of graphene-based DNA biosensors. 16 Isothermal titration calorimetry experiments between graphene and nucleobases revealed that guanine presented the highest interaction energy followed by adenine, cytosine and thymine. 17 Moreover, GO has proven able to load both single-stranded DNA and RNA despite its overall negative charge thanks to hydrophobic and π-π stacking interactions between the ring structures present in NA nucleobases and the GO hexagonal carbon lattice. 18, 19 On the other side, the adsorption of double-stranded NA onto GO flakes is thought to be more complex due to its hydrophilic external structure and less availability of NA bases trapped within the double helix structure. 20 However, other type of driving forces such as hydrogen binding and Van der Waals forces have been proposed on top of π-π stacking interactions to promote the interfacing between double-stranded DNA and GO carbon rings. 21, 22 It has also been suggested that partial deformation of the NA double helix could favor adsorption processes onto the surface of GO. 21 In addition, environmental conditions such as high salt concentrations and low pH have been demonstrated to greatly improve the binding ability of double-stranded NA onto GO. 23 Protection of nucleic acid from enzymatic degradation Several studies have shown the ability of GBMs to prevent NA from enzymatic digestion. Simple experiments performed in the presence of DNAse I showed complete digestion of single-stranded DNA after 60 min incubation whilst no degradation was reported in the case of the GO:single-stranded DNA nanocomplexes in the same conditions. 24 Tang et al. 25 presented similar results in the case of graphene:single-stranded DNA constructs and confirmed their observations thanks to anisotropy analysis of fluorescently labeled single-stranded DNA. However, this protective effect seems more controversial and subject to debate in the case of double-stranded NA. Lei et al. 23 demonstrated that this protective effect was highly dependent on salt concentrations in the case of double-stranded NA and that it could be reversed by the addition of an anionic surfactant such as triton X-100. In addition, enzymatic digestion by DNAse I and EcoR I has been shown to occur even if double-stranded DNA was partially adsorbed onto GO whereas resistance to degradation by Exo III was reported at the same time. 21 Different hypothesis have been stated in the literature to explain the protective effect of nanoparticles such as gold and carbon nanotubes over NA. 26, 27 These include a conformational change in the helical structure that renders NA unrecognizable by enzyme binding pockets and steric hindrance due to the nanomaterial itself that thwarts nuclease digestion. Nevertheless, this effect remains poorly understood in the case of GBMs and further investigation is still required to precisely determine how environmental conditions (for example, salts concentration, pH, material to NA mass ratio) impact or not the enzymatic digestion of both single and doublestranded NA.
Cellular internalization
The presence of GBMs in the intracellular compartments has been observed among others by Sasidharan et al. thanks to confocal microscopy 28 and Huang and et al. 29 via surface-enhanced Raman spectroscopy. However, the underlying mechanisms of cellular internalization of GBMs remain enigmatic and several pathways have been proposed. The two main working hypotheses include phagocytosis and clathrin-mediated endocytosis 30, 31 but the possibility of membrane translocation through a 'piercing effect' has also been revealed from computational studies. 32, 33 Remarkably, photothermal effect due to the ability of graphene to absorb NIR light was suggested to enhance the transfection efficiency thanks to induced heating which locally disrupts the organization of the lipid bilayer cell membrane, hence rendering it more permeable and facilitating endosomal escape. 34 Low toxicity Even though GBMs toxicology studies are still in their infancy and greatly vary depending on the features (for example, lateral dimensions, thickness, chemical modifications and colloidal dispersibility) of the material investigated, preliminary results suggest that GBMs induce lower cytotoxicity than CNTs and that adequate functionalization increases their biocompatibility. 35 So far, GBMs have been reported to mainly accumulate in the lungs, liver and spleen. In most of the cases, no deleterious effects were described after intravenous, intraperitoneal or pulmonary administration of these materials. However, a meta-analysis of the studies published so far revealed the establishment of an inflammatory response in the lungs when the intravenously injected GBMs had low functionalization degree and was administered at high doses for a long time of exposure. 36 Nonetheless, more in vivo data are still needed for an in-depth understanding of the mechanisms governing the body response to GBMs.
STRATEGIES TO OPTIMIZE GBMS AS GENE DELIVERY PLATFORMS
The performance of GBMs as delivery vectors can be improved by different strategies that optimize the loading and release of the NA, or allow the incorporation of other therapeutic or diagnostic agents, among others. Here, we review the most recurring strategies that have been proposed to transform bare GBMs into efficient and safe gene delivery vectors ( Figure 2 ) and discuss the advantages and limitations of such modifications, compiled in Table 2 .
Covalent and non-covalent interactions with cationic polymers, dendrimers and polysaccharides The engraftment of cationic polymers such as polyethylenimine (PEI) to the GBMs surface has been investigated as a strategy to enhance gene transfection efficiency, thanks to the establishment of a cloud of positive charges around the material that favors the electrostatic interactions both with the NA and the cell membrane. In addition, the positive charges of PEI facilitate the release of the cargo from the endosome thanks to the 'proton sponge' effect. The most common approach consists of the covalent engraftment of PEI via EDC/NHS chemistry onto both GO and reduced GO (rGO) flakes. 34, [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] Non-covalent but electrostatic interactions have also been used to anchor PEI onto graphene nanoribbons, 48 GO 49 and rGO/Au composites. 50 Thanks to the above properties, PEI has been used as a non-viral gene delivery vector on its own, however, compromised by its cytotoxicity, especially at high molecular weight (25 kDa) and high nitrogen-to-phosphate ratios. 51 Its combination with GBMs allows the use of low molecular weight PEI with comparable gene complexation efficiencies to that of the high molecular weight counterparts, therefore reducing its cytotoxicity. 52 GBMs with covalently attached polyethylene glycol (PEG) have also been extensively studied for biomedical applications as such modification has shown to increase blood circulation time in vivo, enhance stability under physiological conditions as well as biocompatibility. 53 Exploiting this properties, Feng et al. 34 and Yin et al. 47 elaborated similar GO nanoplatforms covalently engrafted with both PEG and PEI which were able to effectively load EGFP-coding plasmid DNA (pDNA) and plasmid-based stat3 small interfering RNA (siRNA) whilst observing satisfying physicochemical stability of the designed nanoconstructs. PEG has also been used to decorate graphene quantum dots (GQDs), 54 GO 41 and graphene/Au composite 50 for the delivery of various nucleic acids. Interestingly, Zhang et al. compared the loading efficiency of rGO and GO nanoplatforms after covalent functionalization with Figure 2 . Modification strategies to optimize GBMs as non-viral vector platforms. Numerous strategies are available to enhance the performance of GBMs as gene delivery vectors. These include the incorporation of cationic moieties to increase nucleic acid loading, cellpenetrating peptides or acids to enhance cellular internalization and drug and/or imaging agents to build theranostic systems. PEG. The study reported that the engraftment of PEG was able to restore the aqueous dispersibility of rGO and rGO-PEG exhibited better loading capacity and transfection efficacy in HeLa cells compared to GO-PEG. This finding was confirmed thanks to computational modeling and was attributed to the increased availability of aromatic domains in rGO, which facilitated π-π stacking interactions between NA and the carbon lattice. 55 Additionally, cationic dendrimers and polysaccharides have been used for similar purposes. Chitosan (CS), a positively charged linear polysaccharide was covalently linked to GO through EDC/ NHS chemistry in order to improve colloidal dispersibility in PBS and cell culture medium, increasing transfection efficiency whilst inducing lower cytotoxicity. 56, 57 CS is a well-known naturally occurring molecule which has been widely used as a gene/ drug nanocarrier and for the functionalization of nanoparticles in order to improve their aqueous dispersibility. 58 It has also been considered a promising alternative to PEI as it exhibits less cytotoxicity. 59 However, Bao et al. reported much lower transfection efficiency with GO-CS:pDNA nanocomplexes compared to those based on PEI:pDNA alone, implying that the NA transfer efficiency of such vectors is yet to be optimized. 56 Lastly, polyamidoamine (PAMAM) dendrimers consist of a highly spherically ramified polymer which exhibits a biodegradable peptide backbone and a central core that can be filled with therapeutic molecules. PAMAM dendrimers have therefore been widely studied for biomedical applications due to their morphological similarities with spherical proteins, enhanced biocompatibility and easy structural control. 60 In the context of gene delivery, Liu et al. 61 engrafted PAMAM through 1,3 dipolar cycloaddition onto both graphene and GO in order to increase the stability of their nanoconstructs and improve transfection efficiency thanks to the electrostatic interactions occurring between PAMAM and NA. Similarly, Yang et al. 62 covalently linked PAMAM dendrimers thanks to EDC/NHS chemistry in order to improve delivery performance and decrease cytotoxicity.
Functionalization with cell-penetrating peptides To increase the cellular uptake of GBM nanoplatforms, membrane penetrating peptides or acids have been added via various approaches. As an example, oleic acid, which exhibits high affinity for the cell membrane and promotes its destabilization, was used to functionalize graphene and GO in combination with PAMAM dendrimers. 61 Additionally, the cationic cell-penetrating peptide octaarginine was covalently engrafted onto GO flakes 63 or noncovalently and together with a phospholipid-based amphiphilic polymer (PL-PEG) onto rGO by Imani et al. in order to increase cellular uptake. Ren et al. 42 adsorbed the membrane penetrating peptide PV7 to promote nuclear localization of the transfected pDNA. In general, these systems demonstrated superior transfer efficiency compared to their respective bare materials. However, the ratio of cell-penetrating peptide in the formulation has also demonstrated to have a significant impact in the stability of the system. Ren et al. described physical instability at high functionalization ratios that could jeopardize transfection efficiency.
Combination with other nanoparticles
The combination of GBMs with other nanoparticles has been investigated in order to increase transfection efficiency. Xu et al. encapsulated gold nanoparticles (AuNP) and nanorods (AuNR) with GO thanks to self-assembly mechanisms via electrostatic interactions. 43 Interestingly, encapsulated AuNP exhibited improved transfection efficiency compared with encapsulated AuNR and GO-PEI. This result was attributed to their smaller particle size and spherical structure together with the establishment of a GO hydrophilic shell that enhanced biocompatibility. In addition, Cheng et al. 50 used graphene/Au nanocomposite functionalized with PEG and PEI, showing an effective downregulation of Bcl-2. The incorporation of AuNP was thought to improve photothermal effect upon NIR irradiation.
Introduction of cleavable links for tumor-specific targeting Tumor-specific targeting has been achieved through the incorporation of chemical linkages responsive to the tumor microenvironment. Yang et al. 64 synthesized organic-inorganic hybrid materials by decorating GO with poly(2-dimethylamino)ethyl methacrylate (PDMAEMA) thanks to surface initiated atom transfer radical polymerization. This chemical process allowed the introduction of disulfide cleavable bonds between GO and PDMAEMA which enabled the release of the polymer complexed with pDNA under reducing conditions. Qin et al. 41 covalently engrafted doxorubicin onto GO-PEI-PEG using a MMP2 cleavable peptide linkage, consequently allowing the release of doxorubicin only in the presence of the enzyme, which is overexpressed in cancer cells.
PROMISES AND ACHIEVEMENTS OF GBMS AS GENE DELIVERY VECTORS
It has been proposed that GBMs could make a difference as delivery platforms in a number of gene transfer-related applications. Here, we review those for which experimental data has already been shown ( Figure 3 ) and highlight the promises that remain to be demonstrated.
Intracellular molecular sensing
The first studies that used GBMs to deliver a genetic payload into cells pursued the development of intracellular molecular probes. Lu et al. 24 were pioneers in using nanoscale GO for such application. Condensation of a hairpin-shaped DNA molecular beacon (MB) recognizing the survivin transcript to the modified GO sheets proved not only protection of the NA against degradation but also its intracellular delivery in HeLa cells. Importantly, the ability to hybridize to its mRNA target remained intact. The latter was demonstrated by the recovery of fluorescence on hybridization, otherwise quenched in the hairpin conformation. As survivin is a protein overexpressed in many cancers, and frequently associated to multidrug resistance, 65 this system could have potential applications in cancer diagnostics. Almost simultaneously, Wang et al. 66 achieved intracellular delivery of a DNA aptamer/GO nanocomplex in JB6 cells. In this study, GO was proposed as a real-time biosensing platform in living cells. On complexation, GO was able to quench the fluorescence of the carboxyfluorescein-labeled aptamer. However, upon cellular internalization and thanks to the weak interactions governing the complex, the aptamer was able to bind its target, adenosine triphosphate (ATP), and release from the carbon lattice therefore recovering the fluorescent signal. In a different study, Dong et al. 48 similarly developed a method to detect microRNAs in single cells. In this case, the delivery of a MB with high affinity for miR-21 proved more efficient when complexed to PEI-graphene nanoribbons in comparison to other vectors such as PEI alone and PEI-carbon nanotubes. The same group later developed a more sophisticated graphene quantum dot-based system that not only allowed the intracellular imaging of miR-21 but also made it possible to track the internalization of the complex thanks to the strong fluorescent signal emitted by the vector. 54 Finally, Zhang and colleagues highlighted the superior performance of PEG-rGO as biosensing platform, compared to PEG-GO. 55 Expression of exogenous genes Forced expression of foreign genes encoded in pDNA cassettes is to date and by far the most exhaustively explored application of GBMs in the gene transfer field. Most of such studies do not surpass the proof-of-principle stage, assessing transgene expression but without therapeutic goals. They have explored a variety of functionalization strategies, 37, 45, 46, 52, 56, 64 the conjugation to molecules that facilitate cell and nuclear internalization 42, 61, 63 as well as the combination with other nanoparticles, 43 all already discussed in the previous section, in an attempt to increase the efficiency of gene transfer. However, it is difficult to establish direct comparisons between the results achieved by these studies given the numerous factors -for example, type of GBM, lateral dimensions, type and molecular weight of PEI, transfection conditions, cell line used -that can have an impact in transfection efficiency and that are not always accurately described in the reports cited here.
Other more sophisticated studies have taken advantage of the interesting optical and photothermal properties of GBMs to offer additional features to the gene transfer process. Kim and colleagues not only demonstrated the capacity of covalently linked GO-BPEI to force the expression of a luciferase encoding pDNA in two different cancer cell lines, which was superior to that of BPEI low molecular weight alone and comparable to that of BPEI high molecular weight but with reduced cytotoxicity. 38 The authors also made use of the photoluminescent properties of GO-BPEI, which allowed them to follow GO-BEPI/pDNA complexes during transfection by confocal microscopy and to confirm that carrier and nucleic acid payload traveled together inside cells, thanks to complexation with a fluorescently labeled pDNA. This strategy could be therefore useful for bioimaging and internalization studies. The capacity of GBMs to produce heat upon NIR irradiation has also been explored by this and other groups in order to achieve spatially and/or temporally controlled gene transfer. 34, 39 Such a strategy could be of great interest in the development of targeted therapies, the nucleic acid being preferentially delivered at the irradiated area thanks to the facilitation of endosomal escape by local heat. In spite of the numerous studies exploring GBM-mediated gene transfer, most of them have been limited to the delivery of a reporter gene as a proof-of-concept. Only two recent reports have attempted to express genes with either therapeutic purposes or aiming to unchain a change in cell fate. Paul et al. 40 designed a hydrogel formulation able to release PEI-GO/pDNA complexes, where the cassette encoded the vascular endothelial growth factor (VEGF) gene. In vitro, such strategy proved able to efficiently transfect rat cardiomyoblasts, which subsequently produced functionally active VEGF protein. When exposed to the transgenic protein, the proliferation rate of HUVEC endothelial cells increased. In vivo, PEI-GO/pDNA VEGF complexes where injected in the periinfarcted area in a rat model of myocardial infarction, leading to a significant increase in the number of microcapillaries in the area of injection, together with a reduction in scar size and an improvement in cardiac function compared to controls. Choi et al. have not only been first to demonstrate mRNA complexation and efficient delivery by a GO-PEI construct, but also to report the generation of putative induced pluripotent stem (iPS) cells following such a strategy. 67 Delivery of synthetic mRNA or total RNA extracted from pluripotent stem cells generated cell colonies that expressed pluripotency markers, showed a pattern of DNA methylation similar to that of pluripotent cells and were able to differentiate in vitro towards all three germ-layers. Nevertheless, it remains to be proven whether such cells are bona fide pluripotent stem cells, that is, able to contribute to all tissues in an adult organism.
Finally, foreign gene expression has not only been achieved when GBMs were used as delivery vectors in aqueous suspension, Figure 3 . Published work using GBMs as platforms for nucleic acid delivery. All the studies described today have been classified according to three types of applications: gene silencing, exogenous gene expression and molecular sensing.
but also when prepared as cell culture substrates. GO matrixes were able to adsorb PEI/pDNA complexes, which were then gradually released and internalized in the cells cultured on such surfaces. 49 As the substrates can be prepared with different patterns that allow or not the adsorption of PEI/pDNA complexes, this strategy offers spatial control over gene transfer and therefore could be useful in the preparation of genetically different cell populations for the investigation of cell-cell interactions.
Gene silencing Another goal frequently pursued in gene therapy is the silencing or downregulation of genes abnormally overexpressed in a pathological condition. Therefore GBMs have also been tested for the delivery of siRNAs and microRNA (miRNAs). Tripathi et al. 46 used a PEI-GO construct to first deliver a GFP-encoding pDNA and, 3 h later, silence its expression by the delivery of an anti-GFP siRNA using the same vector. Under optimal conditions 70% knockdown was reached, as measured by fluorescence intensity. Encouragingly, a similar GO-PEI:siRNA complex has been recently reported by Huang et al. 68 to efficiently downregulate its intracellular target CXCR4, a chemokine receptor strongly associated to cancer metastasis. This effect reduced the migratory capacity of cancer cells in a wound healing assay. Dong et al. 54 explored the possibility of delivering two anti-sense probes against different targets (miR-21 and survivin) in the same vector, which resulted in a synergistic effect against the growth of HeLa cancer cells.
As in the case of foreign gene expression, the photothermal properties of GBMs can also enhance siRNA delivery. Following this strategy, Feng and collaborators optimized the intracellular internalization of a siRNA against the proto-oncogene Polo-like kinase 1, which resulted in significant downregulation of the target at the mRNA and protein levels. 34 However, the enhancement of siRNA intracellular trafficking is not the only benefit that the photothermal properties of GBMs can offer. Cheng et al. 50 proposed the combination of siRNA delivery and photothermal ablation as a potential anticancer strategy. Their work demonstrated efficient siRNA delivery mediated by a PEG-PEI-rGO/Au vector, which resulted in the downregulation of the anti-apoptotic protein Bcl-2 and, separately, a significant decrease in cell viability when cells were exposed to the vector in the presence of NIR irradiation. Although the synergy of gene silencing and thermal ablation remained unaddressed in this study, it was later confirmed by a different group through a similar strategy. An anit-Stat3 siRNA was delivered by a GO-PEI-PEG vector administered intratumorally, and together with NIR irradiation, in a mouse model of malignant melanoma. 47 Although the administration of the GO-PEI-PEG vectors in the absence of siRNA but with NIR irradiation already resulted in tumor regression, the best results were achieved when combined with Stat3 downregulation.
A different strategy aimed to increase cytotoxicity against cancer cells is the combination of gene silencing and drug delivery. Such approach was first explored with the simultaneous delivery of the anticancer drug doxorubicin and a siRNA targeted against Bcl-2, which is often linked to multidrug resistance, in a PEI-GO vector. The synergy of both therapies was confirmed. 69 In Zhi et al.'s 44 work, a similar rationale was followed with a PEI-PSS-GO carrier for anti-miR-21 siRNA and the anticancer drug adriamycin. When adryamicin-resistant MCF7 cells were exposed to the drug delivered by the vector, their viability was significantly decreased. Noticeably, the drug alone was not effective at all, which confirmed the ability of the carrier to overcome drug resistance mechanisms developed by malignant cells. In addition, the most dramatic reduction in cell viability was achieved when drug and siRNA were concomitantly delivered, which highlights the encouraging potential of combined therapies.
Theranostic platforms Owing once again to its large surface area and the variety of functional groups that can be created on it, it has been possible to design GBMs carriers that not only incorporate NA and drugs for combined therapies, but also encompass imaging contrast agents and therefore serve both as therapeutic and diagnostic tools. Wang et al. 57 developed a multifunctional vector based on chitosan and rGO that incorporated SPIO nanoparticles as MRI contrast agents, the anticancer drug doxorubicin and a reporter pDNA encoding a fluorescent protein. In vitro, this vector exhibited higher cytotoxicity than doxorubicin alone, while gene expression was also confirmed but did not reach the levels of a benchmark transfection reagent. Upon intraperitoneal (i.p.) and intravenous (i.v.) administration, the complexes were preferentially extravasated in the tumor thanks to the enhanced permeation and retention effect and consequently no off-target biodistribution of the pDNA or drug was observed. Ex vivo, this vector also proved as an efficient MRI contrast agent. Qin et al. 41 also advocated for a tumor-targeted theranostic tool, this time by anchoring doxorubicin via a MMP2 cleavable link. The release of the drug from the carrier in cancer cells, in which MMP2 is highly overexpressed, allowed the recovery of its intrinsic fluorescence and could therefore complement the cytotoxic properties of the drug with a method for tumor cell imaging. In non-cancerous cells, the drug remained linked to the vector and no fluorescence was emitted. microRNAs, chemotherapy and imaging agents have also been combined thanks to a gadolinium-functionalized GO (Gd-GO) construct that incorporated the anticancer drug epirubicin and Let-7g miRNA. 62 Let-7g is downregulated in a number of cancers and therefore its concomitant delivery with epirubicin holds great potential as a combined anticancer therapy. In support of this hypothesis, the highest levels of in vitro cytotoxicity were achieved when both the drug and the miRNA were incorporated in the vector, as opposed to those formulations that included only one of the two. In vivo, a similar Gd-GO composite was internalized by brain tumor cells upon intravenous administration and blood-brain barrier disruption. However, the investigation of cytotoxic effects in vivo and tumor regression is yet to be addressed.
FUTURE PERSPECTIVES
A variety of functionalization routes have been investigated in order to optimize NA loading efficiency and intracellular release when using GBMs as gene delivery vectors. However, the poor characterization of such constructs combined with the lack of comparative studies, make it difficult to establish a reliable link between the features of the GBMs nanoplatform (for example, type of GBM, dimensions, thickness, functionalization) and the observed biological effect. Moreover, the underlying mechanisms of cellular internalization of GBMs and NA release within the cytoplasm remain poorly explored. Here again, it is important to mention that the properties of the material used can greatly influence the cellular uptake of the nanocomplexes and consequently impact transfection efficiency. There is therefore a need for more systematic studies able to unveil the relationship between the physicochemical and structural properties of the designed nanoconstructs, the GBMs/cell interface and the biological outcomes shown in vitro and in vivo.
Remarkably, only four out of the twenty-seven studies using GBMs to deliver a genetic payload published so far have provided data on in vivo models, 40, 45, 57, 62 one of them limited to the injection of the material at the one-cell stage of zebrafish embryos. Therefore, one of the main challenges ahead to validate these materials as gene delivery vectors is to confirm whether their encouraging in vitro performance stands in the in vivo setup. Our attention should be also drawn to the fact that the totality of the studies reviewed here have tested the ability of GBMs to transfect dividing cells. Considering that many gene therapy applications will involve the transfer of genetic payloads to post-mitotic cells (that is, skeletal myofibers, neurons, cardiomyocytes), the capacity of GBMs to efficiently transfect genetic materials in the absence of cell division should be promptly investigated.
In conclusion, the use of GBMs as NA nanocarriers is still a very nascent field but has nonetheless shown encouraging preliminary results in numerous proof-of-concept studies. The facile and versatile functionalization of GBMs combined to their unique morphological properties and biological behavior should therefore pave the way for a new generation of non-viral gene delivery vectors.
